Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05944159
Other study ID # 10354421-2022/06-02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 7, 2022
Est. completion date February 20, 2023

Study information

Verified date July 2023
Source Alanya Alaaddin Keykubat University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV).


Description:

Aim: In this study was aimed to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV). Material and Methods; Dix Hallpike maneuver was administered to all patients to confirm the diagnosis at the initial evaluation. If the Dix Hallpike test was positive, Epley maneuver was applied The patients were randomly divided into 2 groups as study group (n=) and control groups (n= ). Temporomandibular joint ve soft tissue techniques were applied 30 minutes once a week for 4 weeks by physiotherapist. Routin medication therapy was applied to control group. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not. Patients were evaluated by Dizziness Disability Inventory (DHI) , Dizziness Assessment- Visual Analogue Scale (VAS), Vertigo Symptom Scale-Short Form (VSS) , Beck Anxiety Inventory (BAI) , Vertigo Dizziness Imbalance Questionnaire (VDI) , Tinnitus Disability Scale (TDS), Romberg Posture Test , Tandem Posture Test, Semitandem Tandem Balance Test, Fonseca's Anamnestic Index (FAI) and amount of mouth opening was measured with goniometer before and after treatment.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date February 20, 2023
Est. primary completion date December 7, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Being diagnosed with positional vertigo, - Being between the ages of 18-65 - Dix Halpike maneuver test (+), - Those who volunteered to participate in the study - Able to read and write. Exclusion Criteria: - Findings of acute or chronic infection at the end of ENT examination, - Considered to have a neurological pathology that causes dizziness, - Head trauma, history of surgical operation, - Having lower extremity pain that prevents standing and weight bearing, - Having a history or symptoms of vestibular system diseases other than BPPV, - Presence of sudden sensory hearing loss and chronic otitis media, - Pregnancy, - The presence of serious cognitive impairment detected by the physician at a level that prevents the tests from being performed, - Not having the mental level to understand and answer the survey questions, - Cervical pathologies that may cause dizziness.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Study Group
Study Group (n= 20) was recieved Temporomandibular joint ve soft tissue techniques. The techniques were applied 30 minutes once a week for 4 weeks by physiotherapist to the study group.
Other:
Control Group
Routin medication therapy was applied to the control group. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not.

Locations

Country Name City State
Turkey Alanyaaku Antalya Alanya

Sponsors (1)

Lead Sponsor Collaborator
Alanya Alaaddin Keykubat University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dizzness Severity dizziness severity was determined by Visual Analog Scale (VAS). The patient is asked to evaluate between 0 and 10 points. A score of "0" means no dizziness, a score of "1-4" means mild dizziness, a score of "4-8" means moderate dizziness, and a score of "10" means unbearable dizziness Baseline - end of the treatment after 4 weeks session
Primary Vertigo Symptom Scale- Shor Form It is a 15-item scale that evaluates dizziness, feeling of imbalance, accompanying autonomic disorders and anxiety symptoms in the last 1 month.Each question has values between 0-4 points. The scores of all items will be added together and the total score will be between 0-60 points. High scores indicate serious problems. A total score of 12 points or more indicates a symptom of vertigo. It has 8 items related to vertigo and has a score between 0-32 points, it has 7 items that includes autonomic complaints and has a score of 0-28. Baseline - end of the treatment after 4 weeks session
Primary Beck Anxiety Inventory It were used for to evaluate of anxiety level because of the vertigo. It consists of 21 questions in total.
0 points: none,
point: mild
points: intermediate,
points: seriously scored. It was classified as mild anxiety symptoms between 8-15 points, moderate anxiety symptoms between 16-25 points, and severe anxiety symptoms between 26-63 points.
Baseline - end of the treatment after 4 weeks session
Primary Vertigo Dizziness Imbalance Questionnaire (VDI) The Vertigo-Dizziness-Imbalance Questionnaire is a scale that evaluates the quality of the daily living activities of the problems that patients experience with vertigo and dizzines.Each question has a point value of "4" points if yes, "0" points if no, and sometimes "2" points. In the scoring, 28 points are the limit points for determining physical disability, 36 points for functional and sensory disability. Baseline - end of the treatment after 4 weeks session
Primary Tinnitus Disability Scale The Tinnitus Disability Scale (TDS) was used for the presence and level of balance tinnitus due to vertigo.TDS has 25 questions. The scoring of the answers is "4", "0" and "2" respectively. The lowest score that can be obtained from the scale is 0 and the highest score is 100. Baseline - end of the treatment after 4 weeks session
Primary Balance Asssesment Balance problems due to vertigo were determined by romberg test, tandem and semitandem tests. Romberg Test:In peripheral vestibular pathologies, the direction of the fall is in that direction. For the Tandem and Semitandem tests,It is asked to try to hold the position for 30 seconds with your open eyes closed. The time it can stand is recorded in seconds Baseline - end of the treatment after 4 weeks session
Primary The presence of Temporomandibular Joint Disorders The presence and level of temporomandibular dysfunction was determined by Fonseca's Anamnestic Index (FAI). FAI is a questionnaire consisting of 10 questions and 3 choices. The answers are "yes" (10 points), "sometimes" (5 points), and "no" (0 points). Scoring TMD No signs or symptoms (0-15 points), mild TMD (20-45 points), moderate TMD (50-65 points), and severe TMD (70-100 points) Baseline - end of the treatment after 4 weeks session
Primary Mouth opening amount of mouth opening was measured with goniometer before and after treatment. Baseline - end of the treatment after 4 weeks session
See also
  Status Clinical Trial Phase
Recruiting NCT03675659 - Intra-articular Magnesium Sulfate for Tmj Dysfunction Early Phase 1
Completed NCT05740826 - Correlation Between Cervical Spine Muscle Disorders and the Occurrence of Symptoms of Temporomandibular Joint Dysfunction
Recruiting NCT05006963 - Tele-Rehabilitation in Patients With Temporomandibular Dysfunction N/A
Active, not recruiting NCT06103851 - Effect of Mask Use on Jaw Functionality
Not yet recruiting NCT02908568 - Stimulation of the Proprioceptive Trigeminocardiac Reflex Phase 2/Phase 3
Completed NCT03119324 - Low Level Laser Therapy in the Treatment of Temporomandibular Joint Disorders (TMJDs) Related Pain N/A
Completed NCT02247063 - Motor Cortex as a Research & Therapeutic Target in TMD N/A
Recruiting NCT06046521 - Impact of Temporomandibular Joint Dysfunction on Objective and Subjective Vocal Measures
Completed NCT00009594 - Alternative Medicine Approaches for Women With Temporomandibular Disorders Phase 2
Completed NCT00010621 - Complementary Medicine Approaches to TMD Pain Management Phase 2
Completed NCT06055855 - Comparing Two-Needle vs. Surgery-Guided Arthrocentesis for TMJ Disorders N/A
Recruiting NCT06035341 - The Association Between Temporomandibular Disorders and Sacroiliac Joint Dysfunction N/A
Completed NCT05821985 - Evaluation of the Effect of Dextrose Prolotherapy Versus Dry Needling Therapy N/A
Completed NCT06005922 - The Effectiveness of Temporomandibular Joint Mobilization and Exercise in Individuals With Chronic Neck Pain N/A
Completed NCT06034756 - Temporomandibular Joint Problems and Core Stabilization
Completed NCT03576079 - Effect of Laser Therapy Versus Anterior Re-positioning Splint in the Treatment of Disc Displacement With Reduction N/A
Completed NCT04557878 - Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction Phase 2
Completed NCT04477122 - Effects of Radial Shock Wave Therapy in the Treatment of Temporomandibular Joint Syndrome. N/A
Completed NCT00237042 - Managing Temporomandibular Disorder (TMD) Symptoms N/A
Completed NCT06132594 - Computed Guided Prolotherapy Versus Conventional Prolotherapy N/A